Validation of the Korean Version of the Bronchiectasis Health Questionnaire

Kim, Hyun Kuk; Lee, Hyun; Kim, Sang‐Heon; Choi, Hayoung; Lee, Jaeha; Lee, Jae Seung; Lee, Sei Won; Oh, Yeon Mok

doi:10.4046/trd.2020.0025

Cited by 9 publications

(7 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The BHQ is comprised of 10 items, with higher scores indicating a better quality-of-life [ 17 ]. A Korean version of the BHQ that was validated in Korean patients with bronchiectasis was used [ 18 ]. Fatigue was assessed using the Korean version of the Fatigue Severity Score (FSS) [ 19 ].…”

Section: Methodsmentioning

confidence: 99%

Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry

Lee

Yong

et al. 2021

BMC Pulm Med

Self Cite

View full text Add to dashboard Cite

Background With the emergence of bronchiectasis as a common respiratory disease, epidemiological data have accumulated. However, the prevalence and impact of psychological comorbidities were not sufficiently evaluated. The present study examined the prevalence of depression and its associated factors in patients with bronchiectasis. Methods This study involved a multicenter cohort of bronchiectasis patients recruited from 33 pulmonary specialist hospitals. The baseline characteristics and bronchiectasis-related factors at enrollment were analyzed. Depressive symptoms were assessed using the Patient Health Questionnaire (PHQ-9). Results Of the 810 patients enrolled in the study, 168 (20.7%) patients had relevant depression (PHQ-9 score ≥ 10), and only 20 (11.9%) patients had a diagnosis of depression. Significant differences were noted in the depressive symptoms with disease severity, which was assessed using the Bronchiectasis Severity Index and E-FACED (all p < 0.001). Depressive symptoms inversely correlated with quality-of-life (r = − 0.704, p < 0.001) and positively correlated with fatigue severity score (r = 0.712, p < 0.001). Multivariate analysis showed that depression was significantly associated with the modified Medical Research Council dyspnea scale ≥ 2 (OR 2.960, 95% CI 1.907–4.588, p = < 0.001) and high number of exacerbations (≥ 3) in the previous year (OR 1.596, 95% CI 1.012–2.482, p = 0.041). Conclusions Depression is common, but its association with bronchiectasis was underrecognized. It negatively affected quality-of-life and presented with fatigue symptoms. Among the bronchiectasis-related factors, dyspnea and exacerbation were closely associated with depression. Therefore, active screening for depression is necessary to optimize the treatment of bronchiectasis. Trial registration The study was registered at Clinical Research Information Service (CRiS), Republic of Korea (KCT0003088). The date of registration was June 19th, 2018.

show abstract

Section: Methodsmentioning

confidence: 99%

Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry

Lee

Yong

et al. 2021

BMC Pulm Med

Self Cite

View full text Add to dashboard Cite

show abstract

“…A consensus definition was used to determine bronchiectasis exacerbation and defined as deterioration in three of the following symptoms for at least 48 h: (1) cough; (2) sputum volume increase and/or consistent change; (3) sputum purulence; (4) dyspnoea and/or exercise intolerance; (5) fatigue and/or malaise; or (6) haemoptysis [ 21 ]. This study also used the following measurement tools related to health-related quality of life: the validated Korean version of the Bronchiectasis Health Questionnaire (BHQ) for quality of life, Patient Health Questionnaire 9 for depression, and Fatigue Severity Score for fatigue [ 3 , 22 ].…”

Section: Methodsmentioning

confidence: 99%

“…(3) sputum purulence; (4) dyspnoea and/or exercise intolerance; (5) fatigue and/or malaise; or (6) haemoptysis [21]. This study also used the following measurement tools related to health-related quality of life: the validated Korean version of the Bronchiectasis Health Questionnaire (BHQ) for quality of life, Patient Health Questionnaire 9 for depression, and Fatigue Severity Score for fatigue [3,22].…”

Section: Assessmentsmentioning

confidence: 99%

Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry

Choi

Lee

Won

et al. 2021

JCM

Self Cite

View full text Add to dashboard Cite

The clinical characteristics of patients with post-tuberculosis (TB) bronchiectasis have not been well evaluated. We enrolled 598 patients with bronchiectasis who participated in the Korean prospective bronchiectasis registry and compared the characteristics of post-TB bronchiectasis (19.7%) with post-infectious (19.6%), idiopathic (40.8%), and other (19.9%) bronchiectasis. The patients with post-TB bronchiectasis had a lower body mass index, higher rate of chronic obstructive pulmonary disease, and lower rate of asthma than those in the other groups. The patients with post-TB bronchiectasis had more upper lobe involvement, more severe radiological extent, and worse lung function than those in the other groups. Long-acting muscarinic antagonist/long-acting ß agonist use and mucolytics were more commonly used in the patients with post-TB bronchiectasis than those in the other groups, while inhaled corticosteroid/long-acting ß agonist was less commonly used. There were no significant intergroup differences in bronchiectasis severity scores except for FACED, the number of exacerbations, and quality of life. Post-TB bronchiectasis is characterised by reduced lung function and higher rates of mucolytic use when compared with other bronchiectasis; thus, adequate bronchodilator use and airway clearance techniques may alleviate symptom burden in this population.

show abstract

“…The translated questionnaires included: QOL-B, BHQ, SGRQ, LCQ, CAT, SOLQ, and SF-36. An additional 14 studies were included since the original review: translated QOL-B was used in Spain (Olveira et al, 2014a, Doña et al, 2018, Máiz et al, 2018, Germany (Ringshausen et al, 2018, Sokol et al 2019 and Brazil (De Camargo et al, 2020); BHQ in Denmark (Gissel et al, 2020) and Korea (Kim et al, 2020); SGRQ in Egypt (Abd-Elazeem et al, 2018), China (Gao et al, 2014b); LCQ in Spain (Máiz et al, 2018), Turkey (Ozalp et al, 2019, Cakmak et al, 2020 and China (Gao et al, 2014b); SOLQ in Turkey (Bulcun et al, 2015); and SF-36 in Turkey (Bekir et al, 2017). All of these studies reported or referenced a validation of the translated questionnaire.…”

Section: Appendixmentioning

confidence: 99%

Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis

et al. 2021

View full text Add to dashboard Cite

IntroductionUnderstanding the psychometric properties of health related quality of life (HRQoL) questionnaires can help inform selection in clinical trials.ObjectiveTo assess the psychometric properties of HRQoL questionnaires in bronchiectasis.MethodsA literature search was conducted. HRQoL questionnaires were assessed for psychometric properties (reliability, validity, minimal clinically important difference (MCID), floor/ceiling effects). Meta-analyses assessed the associations of HRQoL with clinical measures and responsiveness of HRQoL in clinical trials.Results166 studies and 12 HRQoL questionnaires were included. The BHQ, LCQ, CAT and SF-36 had good internal consistency in all domains reported (Cronbach's α≥0.7) across all studies and the QoL-B, SGRQ, CRDQ and SOLQ had good internal consistency in all domains in the majority of (but not all) studies. The BHQ, SGRQ, LCQ and CAT had good test-retest reliability in all domains reported ((intraclass correlation coefficient) ICC ≥0.7) across all studies and the QoL-B, CRDQ and SOLQ had good test-retest reliability in all domains in the majority of (but not all) studies. HRQoL questionnaires were able to discriminate between demographics, important markers of clinical status, disease severity, exacerbations and bacteriology. For HRQoL responsiveness, there was a difference between the treatment and placebo effect.ConclusionSGRQ was the most widely used HRQoL questionnaire in bronchiectasis studies and it had good psychometric properties, however good psychometric data are growing on bronchiectasis specific HRQoL questionnaires, QoL-B and BHQ. Future studies should focus on the medium-long term test-retest reliability, responsiveness and MCID in these HRQoL questionnaires which show potential in bronchiectasis.

show abstract

Validation of the Korean Version of the Bronchiectasis Health Questionnaire

Cited by 9 publications

References 14 publications

Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry

Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry

Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry

Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis

Contact Info

Product

Resources

About